Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SCYX
Stock Latest News
Ratings
Buy Rating Reaffirmed on Scynexis as Rare Disease Pivot and Strong Cash Runway Support Unchanged $4 Price Target
8d ago
SCYX
Premium
The Fly
Scynexis reports Q1 EPS (42c), consensus (12c)
10d ago
SCYX
Premium
The Fly
Scynexis files to sell 87M shares of common stock for holders
20d ago
SCYX
Premium
Company Announcements
SCYNEXIS Director Steven Gilman Announces Board Retirement
1M ago
8K
SCYX
Premium
Ratings
Scynexis: Strategic Pivot to Rare Disease With ADPKD Asset, Strengthened Balance Sheet, and Antifungal Optionality Support Buy Rating and $4 Target
1M ago
SCYX
Premium
Company Announcements
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
2M ago
8K
SCYX
Premium
Company Announcements
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
2M ago
8K
SCYX
Premium
Company Announcements
SCYNEXIS Raises $40 Million in Strategic Private Placement
2M ago
8K
SCYX
Premium
The Fly
Poxel announces sale of PXL770 to Scynexis for up to $196M
2M ago
SCYX
Premium
The Fly
Scynexis completes acquisition of PXL-770 for treatment of kidney disease
2M ago
SCYX
Premium
The Fly
Scynexis announces $40M private placement
2M ago
SCYX
Premium
Ratings
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
2M ago
SCYX
Premium
The Fly
Scynexis announces first patients dosed in Phase 1 SAD, MAD trial of SCY-247
3M ago
SCYX
Premium
The Fly
Cero Therapeutics appoints Eric Francois to board of directors
3M ago
CERO
SCYX
Premium
The Fly
Scynexis announces presentation highlighting data from SCY-247
4M ago
SCYX
Premium
The Fly
Scynexis receives U.S. FDA QIDP, Fast Track Designations for SCY-247
4M ago
SCYX
Premium
The Fly
Scynexis granted 180-day extension by Nasdaq to regain compliance
5M ago
SCYX
Premium
Company Announcements
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
5M ago
SCYX
Premium
The Fly
Scynexis completes transfer of BREXAFEMME NDA to GSK
6M ago
GSK
SCYX
Premium
The Fly
Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration
6M ago
SCYX
Premium
Ratings
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
7M ago
SCYX
Premium
Company Announcements
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
7M ago
SCYX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
